A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy
Completed · Phase 2 · Has a placebo group
Conditions studied: Acute Pain
In brief
This study will evaluate the dose-response relationship and safety of VX-150 in treating acute pain following bunionectomy.
Key facts
- Study ID
- NCT03764072
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 250
- Starts
- 2018-12-12
- Expected to finish
- 2019-01-25
- Last updated by the study team
- 2022-02-09
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arizona Research Center — Phoenix, Arizona, United States
- Anaheim Clinical Trials — Anaheim, California, United States
- Lotus Clinical Research — Pasadena, California, United States
- Chesapeake Research Group — Pasadena, Maryland, United States
- Endeavor Clinical Trials — San Antonio, Texas, United States
- JBR Clinical Research — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.